Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA—a retrospective study of claims data from 2009 TO 2020
Authors:
Open Access
- 21 July 2021
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 40 (12) , 4933-4942
Abstract
Objectives: To compare work absenteeism and short-term disability among adults with psoriasis or psoriatic arthritis (PsA), versus controls in the USA. Methods: Adults eligible for work absenteeism and/or short-term disability benefits between 1/1/2009 and 4/30/2020 were screened in the IBM® MarketScan® Commercial and Health and Productivity Management Databases. The following groups were defined: (1) psoriasis: ≥ 2 psoriasis diagnoses ≥ 30 days apart and no PsA diagnoses; (2) PsA: ≥ 2 PsA diagnoses ≥ 30 days apart; (3) control: absence of psoriasis and PsA diagnoses. Controls were matched to psoriasis and PsA patients based on age, gender, index year, and comorbidities. Non-recreational work absences and sick leaves were evaluated in absentee-eligible patients, and short-term disability was evaluated in short-term disability-eligible patients. Costs (in 2019 USD) associated with each type of work absence were evaluated. Results: 4261 psoriasis and 616 PsA absentee-eligible and 25,213 psoriasis and 3480 PsA short-term disability-eligible patients were matched to controls. Average non-recreational work absence costs were $1681, $1657, and $1217 for the PsA, psoriasis, and control group, respectively. Compared with psoriasis patients and controls, more PsA patients had sick leaves after 1 year (56.2% versus 55.6% and 41.5%, p < 0.0001). Similarly, short-term disability was more frequent in PsA patients than psoriasis patients and controls at year one (8.8% versus 5.6% and 4.7%, p < 0.0001) and corresponding costs were higher ($605, $406, and $335 on average, p < 0.0001). Conclusion: Annual work absenteeism and short-term disability were consistently greater among patients with PsA and psoriasis than controls, highlighting the substantial economic burden of psoriatic disease. Key points• Patients with PsA had greater short-term disability compared with patients with psoriasis and patients with neither psoriasis nor PsA.• Patients with PsA and patients with psoriasis incurred greater non-recreational work absences and sick leaves than patients with neither psoriasis nor PsA.Keywords
This publication has 36 references indexed in Scilit:
- Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational StudiesJournal of the American Heart Association, 2013
- Annual Incremental Health Benefit Costs and Absenteeism Among Employees With and Without Rheumatoid ArthritisJournal of Occupational and Environmental Medicine, 2013
- Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics RegisterRheumatology, 2010
- The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinicsJournal of the European Academy of Dermatology and Venereology, 2010
- Psoriatic Arthritis sine PsoriasisThe Journal of Rheumatology, 2009
- Work disability and health-related quality of life in males and females with psoriatic arthritisAnnals of the Rheumatic Diseases, 2009
- Cost of Moderate to Severe Plaque Psoriasis in Germany: A Multicenter Cost-of-Illness StudyDermatology, 2006
- Disease concomitance in psoriasisJournal of the American Academy of Dermatology, 1995
- A population genetic study of psoriasisBritish Journal of Dermatology, 1994
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987